Brief: Biomerieux Receives FDA 510(K) Clearance Of VIDAS TBI
May 28 (Reuters) - Biomerieux SA BIOX.PA :
* BIOMERIEUX SA - RECEIVES FDA 510(K) CLEARANCE OF VIDAS TBI
(GFAP, UCH-L1)
Source text for Workspace: ID:nNDLs53Tm
Further company coverage: BIOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Biomerieux SA
See all newsBrief: Biomerieux Receives US FDA 510(K) Clearance And Ivdr CE Marking For Vitek Pro
Brief: bioMerieux Receives FDA Clearance For Latest Versions Of Biofire® Filmarray
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Europe Research Roundup: Acceler8 Ventures, Hermes, Soitec
BioMerieux shares rise after Q3 sales beat